Zoetis (ZTS) FCF Payout Ratio Growth (3y) (2015 - 2026)
Zoetis (ZTS) FCF Payout Ratio Growth (3y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.33 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | -65.59% |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 4.33% |
| 5 | United Therapeutics | 22.15 Bn | 19.48 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 10.53% |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.74 Bn | 11.21 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Alkermes | 8.11 Bn | 7.46 Bn | 397.90 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -65.59% |
| Mar 31, 2026 | 34.17% |
| Dec 31, 2025 | -5.36% |
| Sep 30, 2025 | -15.43% |
| Jun 30, 2025 | 6.08% |
| Mar 31, 2025 | 9.60% |
| Dec 31, 2024 | -2.21% |
| Sep 30, 2024 | -2.37% |
| Jun 30, 2024 | -8.68% |
| Mar 31, 2024 | 13.23% |
| Dec 31, 2023 | 26.95% |
| Sep 30, 2023 | -24.13% |
| Jun 30, 2023 | -80.72% |
| Mar 31, 2023 | 10.85% |
| Dec 31, 2022 | 90.64% |
| Sep 30, 2022 | 23.90% |
| Jun 30, 2022 | 29.63% |
| Mar 31, 2022 | 27.72% |
| Dec 31, 2021 | 43.66% |
| Sep 30, 2021 | 20.25% |